These came from a number of major players, including UnitedHealthcare, Aetna, Blue Cross Blue Shield, Fitbit, and a variety of other payers and digital health... (mobihealthnews.com)
The analyst, who would expect similar agreements with other payers and PBMs are already in the works, keeps an Overweight rating on Regeneron shares. (thefly.com)